The Fleming Fund is a £265 million UK aid investment to tackle antimicrobial resistance in low- and middle-income countries around the world. The programme is managed by the UK Department of Health and Social Care, in partnership with Mott MacDonald, the Fleming Fund Grants Management Agent, and LSHTM as host institution.
LSHTM is a host institution to cohorts of Fleming Fund Fellows, currently from Ghana, Kenya and Zimbabwe. The Fleming Fund Fellowship programme is funded by the Department of Health and Social Care, UK Government, with the intention to develop the skills required in leading national institutions to help combat the global threat of antibiotic resistance.
Professional Fellows are supported in building their technical and leadership skills through mentorship support, secondments, specialised training, and participation in the design and implementation of collaborative projects.
- Laboratory Fellowships: Laboratory scientists, primarily senior microbiologists, who are responsible for bacterial culture, antimicrobial sensitivity testing and/or laboratory quality management within national medical and veterinary diagnostic laboratories.
- Surveillance Fellowships: Senior medical and veterinary epidemiologists and others involved in AMR and AMU data analysis and interpretation.
Clare is a professor of Medical Anthropology, Director of the AMR Centre and leads the anthropology of AMR research group. Clare has designed and evaluated complex interventions to improve health worker prescribing practices across a range of health services settings in LMICs, including in Ugandan health centres and drug shops. Clare’s is PI for a number of research projects in Uganda on antimicrobial resistance, exploring why we are so reliant on antimicrobials, and awareness of AMR and providing essential information for designing effective.
Dr Stablers’ research focus is to understand how and why highly virulent bacteria evolve, in particular in response to the antimicrobial challenge. His focus has been nosocomial pathogens especially those are very much in the public and political eye for example Clostridium difficile and MRSA. More recently he has been focused on Acinetobacter baumannii, the human pathogen declared the highest priority by the WHO in 2017. A. baumannii has evolved to be extremely drug resistant with few treatment options in HIC countries and a far worse situation in LMIC countries. He has been using high throughput sequencing technologies to understand the A. baumanniiepidemiology and assessing the use of a bacteriophage depolymerase and ajunct antibody therapy as an alternative to antibiotics employing a disarming rather than kill methodology to reduce the selective pressure that drive AMR.
Catherine has been working in the field of health economics and health systems analysis at LSHTM since 1997. After a first degree in economics at Cambridge, and a Masters in development economics at SOAS, Catherine spent two years working as an economic planner in the Ministry of Health and Social Welfare in Lesotho. After joining LSHTM Catherine's work mainly focused on the economics of malaria control, she completed a PhD on the retail sector and malaria control in Tanzania. Between 2006 and 2011 Catherine was based with the Kenyan Medical Research Institute (KEMRI) / Wellcome Trust Research Programme in Nairobi.
Dr Alex Aiken is a Clinical Associate Professor at LSHTM and a practicing physician in Infectious Diseases and Medical Microbiology. He conducted research work for his PhD into the epidemiology of hospital-acquired infections in Kenya. He conducted post-doctoral research in diverse projects including prevention of surgical site infections in African hospitals (the SUSP study with the WHO), transmission of antibiotic resistant bacteria in hospitals in Zimbabwe (funded by an AMS starter grant), re-analyzing an influential study on the impacts of mass deworming in western Kenya (with Calum Davey, funded by 3ie) and measuring the effects of a training intervention for hospital cleaners in Dar-es-Salaam, Tanzania (the CLEAN study, with Wendy Graham and Giorgia Gon).
Naomi has a multi-disciplinary background in veterinary sciences, infectious disease immunology, vaccine development and public health and works across the social and natural sciences. Naomi joined LSHTM after periods of post-doctoral research at the Royal Veterinary College and the University of Oxford, where she undertook a DPhil.
Naomi has also worked as a policy advisor for the UK government and has a keen interest in addressing the challenges of translating basic science into practical and effective policy design. Naomi is a member of the Royal College of Veterinary Surgeons and an Ambassador for AMR Insights.
Following Katharina's specialist registrar training in Clinical Microbiology and Virology in London in 2015, she became clinical director of the Supranational and National Tuberculosis Reference Laboratory in Germany. Katharina has trained as an epidemiologist at the London School of Hygiene and Tropical Medicine in 2007, followed by a Wellcome Trust funded PhD. During her PhD Katharina investigated the role of active case finding and antiretroviral therapy for tuberculosis control in high HIV and TB prevalence settings in South Africa. Katharina continued to work in sub-Saharan Africa with research mainly focusing on tuberculosis and HIV, including specifically interventions to improve linkage to care, operational and implementation research and diagnostics. More recently in Katharina's role as director of the WHO Supranational Tuberculosis Reference Laboratory, research interests have expanded to multi-drug resistant tuberculosis in Eastern Europe and Central Asia, as well as laboratory quality management and laboratory networks.
Fleming Fellowship Mentor
Ana is interested in antimicrobial usage and antimicrobial resistance. She is currently involved in research projects investigating the supply chain and governance of antibiotics in low and middle income countries (LMICs) and in the UK taking a One Health approach. She is also interested in interdisciplinary and participatory research of zoonotic and foodborne diseases.
Fleming Fellowship Mentor
During Ben's PhD at the University of Nottingham, he developed novel diagnostics for mycobacterial diseases, based on using bacteriophage. Ben successfully patented this technology and he is currently funded to develop this and novel technology further to aid the diagnosis of mycobacterial diseases in human and veterinary settings. Ben is involved in researching drivers of antimicrobial resistance (AMR) in the environment, where he aims to fill in the significant gaps in research in this area, to address the potential risks the environment poses in the spread of AMR, both in the UK and in low-middle income countries.
Fleming Fellowship Mentor
Claire is a veterinarian with training in the social sciences. She joined LIDC and RVC from the School of Veterinary Sciences at the University of Bristol where as Head of Infection and Immunity she initiated the Risk and Resilience Hub which explores four inter-linked critical global challenges: climate change and health, antimicrobial resistance, sustainable food systems and disease emergence. Claire has extensive experience of inter-disciplinary research grounded in the challenges faced by poorer communities. For example, in 2000, she founded the Livestock Development Group (LDG) at the School of Agriculture, Policy and Development at the University of Reading. This was in response to the need for a meta-disciplinary approach to the problems faced by the global poor.
In this seminar, the LSHTM’s role as the host institution will be introduced, and the projects of three Ghanaian fellows will be presented, representing laboratory and antibiotic use projects in human and animal health.
Event details here.